Skip to main content
. Author manuscript; available in PMC: 2011 Jun 23.
Published in final edited form as: Am J Psychiatry. 2010 Mar 15;167(6):668–675. doi: 10.1176/appi.ajp.2009.08060852

Table 2.

In-trial patient outcomes for drinking and depression, expressed as percentage of patients or means

Patients (N=170) Sertraline +
Naltrexone
Naltrexone Sertraline Placebo Sertraline + Naltrexone group vs.
other groups combined


P
rimary Outcomes -
Drinking and Depression

%
or
M
N SD
%
or
M
N SD
%
or
M
N SD
%
or
M
N SD
χ2
or
t
p
Odds Ratio
or
Cohen's d
95% CI
Total Abstinence in Tx
(% patients)
53.7%
(n=41)
22 21.3%
(n=47)
10 27.5%
(n=40)
11 23.1%
(n=39)
9 12.9 0.001 OR = 3.7 1.8 – 7.8
Time (days) to Relapse to
Heavy Drinking (≥5
drinks/drink day--men; ≥4
drinks/drink day--women)
Md=98
63.6
(n=41)
40.8 Md=29
45.2
(n=47)
38.9 Md=23
39.9
(n=40)
38.3 Md=26
41.7
(n=39)
38.0 3.0 0.003 d = 0.54 .19 – .89
Not Depressed at Tx End
(% patients w/Hamilton
depression rating ≤ 9 in Last
3 Tx Weeks)
83.3%
(n=30)
25 68.8%
(n=32)
22 48.1%
(n=27)
13 56%
(n=25)
14 6.1 0.014 OR = 3.6 1.2 – 10.2
Hamilton Rating of
Depression at Tx End
6.9
(n=27)
6.1 8
(n=29)
7.0 11.7
(n=26)
7.3 10.2
(n=21)
8.0 2.1 0.042 d = 0.44 .02 – .87

M = Mean; SD = Standard Deviation; CI = Confidence Interval; Tx = Treatment; OR = Odds Ratio; Md = Median; d = Cohen's statistic